(Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 81.99%-109.4K | -91.76%110.19K | -87.03%197.48K | 131.60%757.6K | 31.71%-199.37K | -176.03%-607.44K | 52.04%1.34M | 455.21%1.52M | 434.80%327.12K | -130.04%-291.95K |
Net income from continuing operations | -162.25%-849.11K | 128.74%136.24K | 40.43%507.8K | 591.38%101.75K | -61.85%-149.54K | 57.28%-323.78K | -362.90%-473.97K | 58.85%361.61K | 101.75%14.72K | 80.43%-92.39K |
Depreciation and amortization | 98.85%231.31K | -64.68%455.43K | -61.29%119.52K | -59.00%134.78K | -48.27%169.78K | -64.09%116.32K | 13.94%1.29M | 9.26%308.79K | 17.22%328.71K | 15.44%328.21K |
Remuneration paid in stock | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
Other non cashItems | -13.82%45.98K | 20.67%200.51K | 5.70%45.96K | 964.39%50.15K | 11.26%51.04K | -25.99%53.36K | -5.93%166.16K | 36.05%43.48K | -90.53%4.71K | 13.04%45.87K |
Change In working capital | 208.61%462.42K | -289.22%-681.99K | -163.84%-475.81K | 20,874.50%435.02K | 62.30%-207.17K | -355.39%-425.76K | 160.21%360.43K | 389.34%745.28K | -100.51%-2.09K | -149.10%-549.46K |
-Change in receivables | 448.19%475.4K | -63.19%175.32K | -34.86%287.36K | 1,448.60%910.24K | 72.52%-76.77K | -153.40%-136.54K | 297.72%476.22K | 340.63%441.11K | -83.07%58.78K | -170.08%-279.36K |
-Change in inventory | 72.45%-37.52K | 295.43%693.25K | 1,554.29%667.34K | 195.80%269.96K | -1,304.00%-107.85K | -11.42%-136.19K | -162.73%-354.73K | 156.14%40.34K | -1,542.28%-281.8K | 105.70%8.96K |
-Change in payables and accrued expense | 81.75%-23.56K | -160.11%-92.6K | -3.71%143.72K | -360.20%-608.84K | 1,750.56%243.39K | -204.17%-129.13K | 232.39%154.07K | 185.97%149.25K | 44.04%-132.3K | -97.79%13.15K |
-Change in other current assets | 55.64%-57.34K | -102.88%-18.79K | -179.98%-78.91K | -96.54%25.71K | -287.07%-94.84K | 46.07%-129.26K | 205.35%652.11K | -11.85%98.66K | 1,174.25%742.4K | 108.00%50.7K |
-Change in other current liabilities | --17.93K | --72.2K | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
-Change in other working capital | -16.93%87.51K | -166.45%-1.51M | -9,943.66%-1.57M | 58.36%-162.05K | 50.11%-171.09K | -29.26%105.35K | -201.80%-567.22K | -73.14%15.92K | -199.78%-389.18K | -124.16%-342.91K |
Interest paid (cash flow from operating activities) | --0 | --0 | --0 | ---- | -162.68%-63.48K | -10.93%-27.58K | 54.40%-4.76K | 705.77%63.2K | ---18.93K | ---24.17K |
Interest received (cash flow from operating activities) | ---- | ---- | ---- | --35.9K | ---- | ---- | ---- | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 81.99%-109.4K | -91.76%110.19K | -87.03%197.48K | 131.60%757.6K | 31.71%-199.37K | -176.03%-607.44K | 52.04%1.34M | 455.21%1.52M | 434.80%327.12K | -130.04%-291.95K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -38.00%-171.47K | 139.12%733.77K | 170.98%1.2M | -127.18K | -743.08%-468.27K | -1.20%-124.25K | -198.72%-1.88M | -1.7M | 0 | -55.54K |
Net PPE purchase and sale | ---- | ---5.62K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
Net intangibles purchas and sale | -38.00%-171.47K | -17.93%-615.01K | 58.10%-143.81K | ---127.18K | -743.08%-468.27K | -1.20%-124.25K | 16.96%-521.52K | ---343.2K | --0 | ---55.54K |
Net other investing changes | ---- | 200.00%1.35M | ---- | ---- | ---- | ---- | ---1.35M | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -38.00%-171.47K | 139.12%733.77K | 170.98%1.2M | ---127.18K | -743.08%-468.27K | -1.20%-124.25K | -198.72%-1.88M | ---1.7M | --0 | ---55.54K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -82.46%-140.75K | 29.13%-497.65K | 52.61%-191.26K | -187.62%-50.24K | -2.93%-204.76K | 60.08%-77.14K | 37.26%-702.19K | -81.27%-403.61K | 111.44%57.34K | 61.15%-198.94K |
Net issuance payments of debt | -28.05%-98.77K | 42.35%-404.78K | 75.62%-98.39K | -187.62%-50.24K | -2.93%-204.76K | 60.08%-77.14K | 11.71%-702.19K | -66.90%-403.61K | 134.09%57.34K | -20.45%-198.94K |
Net other financing activities | ---41.97K | ---92.87K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -82.46%-140.75K | 29.13%-497.65K | 52.61%-191.26K | -187.62%-50.24K | -2.93%-204.76K | 60.08%-77.14K | 37.26%-702.19K | -81.27%-403.61K | 111.44%57.34K | 61.15%-198.94K |
Net cash flow | ||||||||||
Beginning cash position | 24.57%2.45M | -33.72%1.97M | -47.16%1.13M | -80.31%374.41K | -45.25%1.33M | -33.72%1.97M | -23.16%2.97M | -40.07%2.14M | -53.31%1.9M | -31.09%2.43M |
Current changes in cash | 47.87%-421.61K | 127.91%346.31K | 309.24%1.21M | 50.91%580.19K | -59.66%-872.4K | -50.88%-808.83K | -43.03%-1.24M | -0.42%-578.85K | 164.21%384.45K | -218.84%-546.42K |
Effect of exchange rate changes | -142.74%-73.96K | -43.29%136.59K | -73.42%108.48K | 216.35%174.16K | -533.71%-82.94K | 44,700.00%173.05K | 1,022.68%240.88K | 1,874.95%408.08K | -265.16%-149.69K | -78.30%19.12K |
End cash Position | 46.86%1.95M | 24.57%2.45M | 24.57%2.45M | -47.16%1.13M | -80.31%374.41K | -45.25%1.33M | -33.72%1.97M | -33.72%1.97M | -40.07%2.14M | -53.31%1.9M |
Free cash from | 61.61%-280.86K | -162.56%-510.44K | -95.93%48.05K | 92.72%630.43K | -92.13%-667.64K | -113.42%-731.69K | 224.16%815.95K | 433.29%1.18M | 434.80%327.12K | -135.75%-347.49K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.